NEXT

Amaris Elliott Engel

Amaris Elliott Engel

November 11, 2014 | National Law Journal

Plaintiffs Renew Bid to See Diabetes Drug Reports

More than 540 plaintiffs alleging they developed pancreatic cancer by taking one of four Incretin-based drugs have asked a federal judge to reconsider his ban on discovery into adverse events involving those drugs that were reported to the Food and Drug Administration.

By Amaris Elliott-Engel

3 minute read

November 10, 2014 | National Law Journal

Some Plaintiffs Trying to Abandon Vaginal Mesh MDL

Several plaintiffs suing Coloplast Corp. over its pelvic mesh products have moved to initiate discovery because they claim the goal of coordinating the cases into multidistrict litigation has been defeated.

By Amaris Elliott-Engel

2 minute read

November 07, 2014 | Connecticut Law Tribune

Second Circuit Upholds Tribal Leader's Conviction

Michael Thomas had a reputation as a "tireless and effective advocate" for the Mashantucket Pequot Tribal Nation, and he rose to president of the tribal council, a position he held for nine years, despite a difficult childhood. But now, with his conviction recently upheld by the U.S. Court of Appeals for the Second Circuit, Thomas will spend 18 months in federal prison for embezzling more than $100,000 in tribal funds.

By Amaris Elliott-Engel

5 minute read

November 05, 2014 | National Law Journal

Medical Device Makers Urged to Adopt Cybersecurity Controls

Manufacturers of medical devices should incorporate specific controls into the designs of their products to address cybersecurity, the U.S. Food and Drug Administration's Abiy Desta said on a recent webinar.

By Amaris Elliott-Engel

2 minute read

November 05, 2014 | National Law Journal

Louisiana Court Rejects School Employees' Katrina-Related Claims

The Louisiana Supreme Court has rejected a class action brought by 7,600 public school employees who lost their jobs in the wake of Hurricane Katrina because three separate cases were already brought by a teachers union over the employees' termination.

By Amaris Elliott-Engel

3 minute read

November 05, 2014 | National Law Journal

Pfizer Seeks Dismissal of Zoloft Claims

With all four plaintiffs witnesses rejected in litigation alleging that antidepressant Zoloft causes birth defects, Pfizer Inc. has moved to have all 526 cases struck at the summary judgment stage.

By Amaris Elliott-Engel

2 minute read

November 05, 2014 | National Law Journal

GAF Shingles Class Actions' Settlement Is Open-Ended

A federal judge has provisionally approved settlements in nine class actions in which plaintiffs allege that Timberline shingles made by GAF Materials Corp. were prone to cracking, tearing or splitting.

By Amaris Elliott-Engel

2 minute read

November 04, 2014 | National Law Journal

Expert Ordered to Comply In Toyota Lawsuit Leak Probe

A federal judge has ordered a plaintiffs expert in the litigation over Toyota's sudden-acceleration defect to comply with a demand to explain how confidential discovery materials were leaked into the public domain.

By Amaris Elliott-Engel

2 minute read

November 04, 2014 | National Law Journal

Drugmakers in Opioids Suit Urge Trade-Secrets Shield

Two drugmakers being sued by the city of Chicago for allegedly masking the downsides of opiate-based painkillers don't want the city's amended complaint to be unsealed in its entirety.

By Amaris Elliott-Engel

2 minute read

November 04, 2014 | National Law Journal

Judge Rebukes Both Sides of Potato Price-Fixing Case

A federal magistrate in multidistrict litigation over alleged price-fixing of potatoes has decided that neither side is correct about whether 1,100 documents are protected by the attorney-client privilege.

By Amaris Elliott-Engel

2 minute read


More from ALM